Collecting Duct Carcinoma Clinical Trials

8 clinical trials for Collecting Duct Carcinoma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors — RECRUITING · PHASE2
• Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma — RECRUITING · PHASE2
• Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma — RECRUITING · PHASE2
• Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study — ACTIVE_NOT_RECRUITING · PHASE2
• Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer — WITHDRAWN · PHASE2
• Collecting Ducts Carcinoma: in Depth Exploration and Biologically Driven Therapy (CICERONE) — OTHER
• caBozantinib in cOllectiNg ductS Renal Cell cArcInoma — COMPLETED · PHASE2
• Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24) — COMPLETED · PHASE2

Refine this search